Canada markets closed

Syros Pharmaceuticals, Inc. (0S90.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
4.7000+0.1200 (+2.62%)
At close: 08:09AM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 127.63M
Enterprise Value 54.93M
Trailing P/E 8.89
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)13.91
Price/Book (mrq)7.75
Enterprise Value/Revenue 5.53
Enterprise Value/EBITDA -0.35

Trading Information

Stock Price History

Beta (5Y Monthly) 1.78
52-Week Change 370.90%
S&P500 52-Week Change 325.01%
52 Week High 37.4400
52 Week Low 31.9700
50-Day Moving Average 35.6648
200-Day Moving Average 34.3780

Share Statistics

Avg Vol (3 month) 326
Avg Vol (10 day) 3N/A
Shares Outstanding 526.45M
Implied Shares Outstanding 627.87M
Float 811.26M
% Held by Insiders 11.08%
% Held by Institutions 181.58%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Sept 19, 2022

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-6,996.11%

Management Effectiveness

Return on Assets (ttm)-38.32%
Return on Equity (ttm)-227.95%

Income Statement

Revenue (ttm)9.94M
Revenue Per Share (ttm)0.35
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -124.25M
Net Income Avi to Common (ttm)-164.57M
Diluted EPS (ttm)-5.4500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)139.53M
Total Cash Per Share (mrq)5.27
Total Debt (mrq)62.08M
Total Debt/Equity (mrq)372.55%
Current Ratio (mrq)3.95
Book Value Per Share (mrq)0.63

Cash Flow Statement

Operating Cash Flow (ttm)-109.71M
Levered Free Cash Flow (ttm)-66.66M